Sermaglutide Powder CAS 910463 68 2

 Synthetic Sermaglutide Powder CAS 910463 68 2

Introduction:

Semaglutide, sold under the brand name Ozempic among others, is an antidiabetic medication used for the treatment of type 2 diabetes and long-term weight management.[15][16][17]

Semaglutide acts like human glucagon-like peptide-1 (GLP-1) in that it increases insulin secretion, thereby increasing sugar metabolism. It is distributed as a metered subcutaneous injection in a prefilled pen, or as an oral form. One of its advantages over other antidiabetic drugs is that it has a long duration of action, so a once-a-week injection is sufficient.[18]

An injectable version (Ozempic) was approved for medical use in the United States in December 2017,[19] and in the European Union,[12] Canada,[20] and Japan in 2018. A version which is taken by mouth (Rybelsus) was approved for medical use in the United States in September 2019,[21] and in the European Union in April 2020.[13] It is the first glucagon-like peptide receptor protein treatment approved for use in the United States that does not need to be injected.[22] It was developed by Novo Nordisk. Side effects include nausea, vomiting, diarrhea, abdominal pain, and constipation.[9]

In June 2021, the US Food and Drug Administration (FDA) approved semaglutide injection sold under the brand name Wegovy for long-term weight management in adults

Currently, several drugs commonly used in clinical treatment of premenopausal breast cancer and prostate cancer by ovarian removal (referred to as GNRH-A drugs)  

Semaglutide is a new generation of glP-1 chemicalbook (glucagon-like peptid-1) analogue developed by NovoNordisk, Denmark. Semaglutide is a long-acting formulation based on the basic structure of liraglutide, which is better for the treatment of type 2 diabetes  

Fuction &Application:

Semaglutide is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.[9][10]

Semaglutide may be administered in combination with other antidiabetic drugs; dose of concomitant insulin or sulfonylurea may need to be reduced.[23]

Semaglutide (Wegovy) is also indicated as an adjunct to diet and exercise for long-term weight management in adults with obesity (initial body mass index (BMI) ≥ 30 kg/m2) or overweight (initial BMI ≥ 27 kg/m2) with at least one weight-related comorbidity.

                                 Certificate of Analysis

Storage:In an air tight container,protected from light at temperature2-8℃. Conclusion:the product complies with enterprise standard.

Not for human use without further processing.

Why Choose Us:

1.Stable quality, high quality satisfy customer's high grade sourcing request.
2.Competitive price .
3.Correct delivery time promise.
4.Continuous improvement make sure the long-term cooperation.
5.Honest service for your whole sourcing process.

Ench Industry is the professional Oxytocin CAS 50-56-6
Welcome your inquiry and cooperation ,feel free to contact with us !

Contact us:
Call us by 008613675847137
Email us at  jayjie@hjy.com
Contact by QQ 1430571263